Report Detail
Global Pericarditis Market Size, Status and Forecast 2019-2025
- RnM2799997 |
- 12 July, 2019 |
- Global |
- 96 Pages |
- QYResearch |
- Other
Pericarditis is inflammation of the pericardium (the fibrous sac surrounding the heart). Symptoms typically include sudden onset of sharp chest pain. The pain may also be felt in the shoulders, neck, or back. It is typically better sitting up and worse with lying down or breathing deep. Other symptoms may include fever, weakness, palpitations, and shortness of breath. Occasionally onset of symptoms is gradual.
Treatment in most cases is with NSAIDs and possibly colchicine. Steroids may be used if those are not appropriate. Typically symptoms improve in a few days to weeks but can occasionally last months. Complications can include cardiac tamponade, myocarditis, and constrictive pericarditis. It is a less common cause of chest pain. About 3 per 10,000 people are affected per year. Those most commonly affected are males between the ages of 20 and 50. Up to 30% of those affected have more than one episode.
In 2018, the global Pericarditis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Pericarditis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pericarditis development in United States, Europe and China.
The key players covered in this study
Pfizer
Astrazeneca
Bayer
Reckitt Benckiser
Perkinelmer
Fujifilm
Merck Sharp & Dohme
Allergan
Market segment by Type, the product can be split into
Acute Pericarditis
Chronic Pericarditis
Recurrent Pericarditis
Market segment by Application, split into
Hospitals & Clinics
Medical Institutes
Research Organization
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Pericarditis status, future forecast, growth opportunity, key market and key players.
To present the Pericarditis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Pericarditis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Pericarditis Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Acute Pericarditis
- 1.4.3 Chronic Pericarditis
- 1.4.4 Recurrent Pericarditis
- 1.5 Market by Application
- 1.5.1 Global Pericarditis Market Share by Application (2014-2025)
- 1.5.2 Hospitals & Clinics
- 1.5.3 Medical Institutes
- 1.5.4 Research Organization
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Pericarditis Market Size
- 2.2 Pericarditis Growth Trends by Regions
- 2.2.1 Pericarditis Market Size by Regions (2014-2025)
- 2.2.2 Pericarditis Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Pericarditis Market Size by Manufacturers
- 3.1.1 Global Pericarditis Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Pericarditis Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Pericarditis Market Concentration Ratio (CR5 and HHI)
- 3.2 Pericarditis Key Players Head office and Area Served
- 3.3 Key Players Pericarditis Product/Solution/Service
- 3.4 Date of Enter into Pericarditis Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Pericarditis Market Size by Type (2014-2019)
- 4.2 Global Pericarditis Market Size by Application (2014-2019)
5 United States
- 5.1 United States Pericarditis Market Size (2014-2019)
- 5.2 Pericarditis Key Players in United States
- 5.3 United States Pericarditis Market Size by Type
- 5.4 United States Pericarditis Market Size by Application
6 Europe
- 6.1 Europe Pericarditis Market Size (2014-2019)
- 6.2 Pericarditis Key Players in Europe
- 6.3 Europe Pericarditis Market Size by Type
- 6.4 Europe Pericarditis Market Size by Application
7 China
- 7.1 China Pericarditis Market Size (2014-2019)
- 7.2 Pericarditis Key Players in China
- 7.3 China Pericarditis Market Size by Type
- 7.4 China Pericarditis Market Size by Application
8 Japan
- 8.1 Japan Pericarditis Market Size (2014-2019)
- 8.2 Pericarditis Key Players in Japan
- 8.3 Japan Pericarditis Market Size by Type
- 8.4 Japan Pericarditis Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Pericarditis Market Size (2014-2019)
- 9.2 Pericarditis Key Players in Southeast Asia
- 9.3 Southeast Asia Pericarditis Market Size by Type
- 9.4 Southeast Asia Pericarditis Market Size by Application
10 India
- 10.1 India Pericarditis Market Size (2014-2019)
- 10.2 Pericarditis Key Players in India
- 10.3 India Pericarditis Market Size by Type
- 10.4 India Pericarditis Market Size by Application
11 Central & South America
- 11.1 Central & South America Pericarditis Market Size (2014-2019)
- 11.2 Pericarditis Key Players in Central & South America
- 11.3 Central & South America Pericarditis Market Size by Type
- 11.4 Central & South America Pericarditis Market Size by Application
12 International Players Profiles
- 12.1 Pfizer
- 12.1.1 Pfizer Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Pericarditis Introduction
- 12.1.4 Pfizer Revenue in Pericarditis Business (2014-2019)
- 12.1.5 Pfizer Recent Development
- 12.2 Astrazeneca
- 12.2.1 Astrazeneca Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Pericarditis Introduction
- 12.2.4 Astrazeneca Revenue in Pericarditis Business (2014-2019)
- 12.2.5 Astrazeneca Recent Development
- 12.3 Bayer
- 12.3.1 Bayer Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Pericarditis Introduction
- 12.3.4 Bayer Revenue in Pericarditis Business (2014-2019)
- 12.3.5 Bayer Recent Development
- 12.4 Reckitt Benckiser
- 12.4.1 Reckitt Benckiser Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Pericarditis Introduction
- 12.4.4 Reckitt Benckiser Revenue in Pericarditis Business (2014-2019)
- 12.4.5 Reckitt Benckiser Recent Development
- 12.5 Perkinelmer
- 12.5.1 Perkinelmer Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Pericarditis Introduction
- 12.5.4 Perkinelmer Revenue in Pericarditis Business (2014-2019)
- 12.5.5 Perkinelmer Recent Development
- 12.6 Fujifilm
- 12.6.1 Fujifilm Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Pericarditis Introduction
- 12.6.4 Fujifilm Revenue in Pericarditis Business (2014-2019)
- 12.6.5 Fujifilm Recent Development
- 12.7 Merck Sharp & Dohme
- 12.7.1 Merck Sharp & Dohme Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Pericarditis Introduction
- 12.7.4 Merck Sharp & Dohme Revenue in Pericarditis Business (2014-2019)
- 12.7.5 Merck Sharp & Dohme Recent Development
- 12.8 Allergan
- 12.8.1 Allergan Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Pericarditis Introduction
- 12.8.4 Allergan Revenue in Pericarditis Business (2014-2019)
- 12.8.5 Allergan Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Pericarditis . Industry analysis & Market Report on Pericarditis is a syndicated market report, published as Global Pericarditis Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Pericarditis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
